Imagion Podcast Episode 2: Mike Harsh speaks with Marisa Zammit from WE Communications

Marisa Zammit asks Mike about his background, how Mike came to join Imagion and how Mike thinks Imagion's technology could transform the imaging industry.…


Imagion Biosystems receives $300K order for supply of nanoparticles

Imagion Biosystems Limited announced the NewPhase Ltd., an Israeli biotechnology company developing cancer treatments, has placed an order totaling…


Imagion features in Mergermarkets

Imagion CEO Bob Proulx discusses the company's path to first-in-human trials plus early discussions with potential partners and strategic investors in this…


Mike Harsh Addresses Investors in Sydney, Australia

Non-Executive Director Mike Harsh addresses Imagion Biosystems' investors. November, 2019.


Finfeed interview with Mike Harsh

Interview: Mike Harsh on the evolution of Imaging and Imagion's role With over 40 years' experience in the health care diagnostic imaging industry, Imagion…


Bob Proulx Discusses Imagion's Recent Progress with Boardroom Media

Funds raised in Imagion’s recent Rights Issue will be used to fund the first-in-human trials for the Company’s MagSense technology. Listen to CEO Bob Proulx…


Imagion Biosystems' Patent Issued in India

Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, has been issued patent #320872 from…